Skip to main navigation Skip to search Skip to main content

Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study

  • Interventional Pulmonary Outcomes Group

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1384-1392
Number of pages9
JournalChest
Volume162
Issue number6
DOIs
StatePublished - Dec 2022

ASJC Scopus Subject Areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Keywords

  • bleeding
  • empyema
  • fibrinolysis
  • intrapleural
  • parapneumonic pleural effusion
  • Pleural Effusion/complications
  • Enzyme Therapy
  • Pleural Diseases/complications
  • Humans
  • Communicable Diseases
  • Hemorrhage/chemically induced
  • Tissue Plasminogen Activator/adverse effects
  • Fibrinolytic Agents/adverse effects
  • Retrospective Studies
  • Empyema, Pleural/drug therapy

Cite this